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Influenza C Virus
Infection in
Children, Spain 
To the Editor: Influenza viruses
cause serious respiratory illness, par-
ticularly in infants <24 months of age
(1). Despite serologic studies of
French adults that showed an influen-
za virus seroprevalence of 60%–70%,
influenza C infections have rarely
been described (2). Given the techni-
cal difficulties involved in isolating
influenza C virus in cell cultures,
diagnosis is made only in certain lab-
oratories. Detection of viral genome
by reverse transcription (RT)–PCR in
nasopharyngeal aspirates allows etio-
logic diagnosis of these infections (3).
Mild upper respiratory infections in
adults and adolescents are attributed
to this virus (4,5). Some cases of
lower respiratory infections have also
been described in children (6).
A prospective study was conduct-
ed from September 1999 through July
2003. We determined the incidence
and clinical manifestations associated
with influenza C infection  in all chil-
dren <24 months of age admitted to
Severo Ochoa Hospital in Madrid,
Spain, with respiratory tract infections
both with and without fever. All
patients were evaluated by an attend-
ing physician. The study was
approved by the Fondo de
Investigaciones Sanitarias Committee
of Spain.
Specimens of nasopharyngeal
aspirates were obtained from each
patient on admission (Monday to
Friday) and sent to the Respiratory
Virus Laboratory at the National
Microbiology Center in Madrid for
virologic studies. Specimens were
processed within 24 hours of collec-
tion.
A multiplex RT-PCR was used for
direct detection of respiratory syncy-
tial virus A (RSV-A), RSV-B, aden-
oviruses, and influenza A, B, and C
viruses in all nasopharyngeal samples,
as previously described (7). Primers
were specific for the nucleoprotein
gene segment of influenza virus, the
fusion gene of RSV, and the hexon
gene of adenoviruses.
An internal amplification control
was included in the reaction mixture
to exclude false-negative results
caused by specimen inhibitors or
extraction failure. Given the high sen-
sitivity of nested PCR, precautions
were taken to prevent reactions from
being contaminated with previously
amplified product, as well as to pro-
tect target RNA or DNA from other
specimens and controls. All proce-
dures were performed in laboratory
safety cabinets at locations different
from those where amplified products
were analyzed. Detection levels of 0.1
and 0.01 50% tissue culture infectious
doses of influenza A and B viruses
and 1–10 molecules of cloned ampli-
fied products of influenza C virus,
RSV-A, RSV-B, and adenovirus
serotype 1 were achieved.
A total of 706 hospitalized infants
were enrolled in the study; 496 speci-
mens were positive for virus (76.1%
were RSV). Thirty children were
infected with influenza virus (4.3% of
all respiratory infections and 6% of all
confirmed viral infections). Six
patients had confirmed influenza C
virus infections. Three of them had
co-infections, 2 with RSV and 1 with
adenovirus. Clinical characteristics of
these 6 patients are shown in the
Table. Although clinical characteris-
tics for 24 influenza Avirus infections
were similar to those for influenza C
virus infections (no influenza B virus
was identified), statistical analysis
was not conducted because of small
sample size.
Influenza virus infections are a
major cause of hospitalization and ill-
ness in young children, particularly
those <2 years of age (1). Influenza A
virus infections are more common
than influenza B virus infections
(75% vs 25%) (8). Our results indi-
cate that influenza C virus is presentLETTERS
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in infants hospitalized with respirato-
ry infections.
In contrast to data for adults, in
whom influenza C virus infection is
associated with mild upper respiratory
infections (5), our study showed that
this infection in infants may be asso-
ciated with illness severe enough to
require hospitalization. Clinical
symptoms of influenza C virus infec-
tion in our patients, such as high fever
and respiratory symptoms, were simi-
lar to those described for infections
with influenza A and B viruses
(1,8,9). Nonrespiratory symptoms
such as fever or diarrhea have often
been associated with influenza A and
B virus infections (9). Three patients
with influenza C virus infections had
diarrhea; 2 had rotavirus and aden-
ovirus detected in feces, and 1 had
rotavirus detected in feces. However,
the high incidence of co-infections
makes clarifying the role of influenza
C virus as a causative agent in these
conditions difficult.
Few studies have investigated
influenza C virus infection in chil-
dren. Katagiri et al. (10) described an
outbreak characterized by fever and
symptoms of upper respiratory infec-
tions in workers and children at a chil-
dren’s home. The largest pediatric
study reported was that of Moriuchi et
al. (6) of 20 cases of influenza C virus
infection in children <15 years of age
compiled in 2 years in a hospital set-
ting among both inpatients and out-
patients. They found clinical results
similar to ours (lower respiratory
infections). However, we could not
make any conclusions about influenza
C virus infections in nonhospitalized
children.
Influenza C virus infection in hos-
pitalized infants is responsible for a
clinical condition with high fever and
respiratory symptoms severe enough
to require hospitalization. This virus
should be studied in respiratory infec-
tions in hospitalized infants to further
clarify its role.
This study was partially supported by
the Fondo de Investigaciones Sanitarias
(FIS no. 98/0310).
Cristina Calvo,* 
Maria Luz García-García,* 
Miriam Centeno,* Pilar Pérez-
Breña,† and Inmaculada Casas†
*Severo Ochoa Hospital, Madrid, Spain;
and †Instituto de Salud Carlos III, Madrid,
Spain
References
1.  Iwane MK, Edwards KM, Szilagyi PG,
Walker FJ, Griffin MR, Weinberg GA, et al.
Population-based surveillance for hospital-
izations associated with respiratory syncy-
tial virus, influenza virus, and parainfluen-
za virus among young children. Pediatrics.
2004;113:1758–64.
2. Manuguerra JC, Hannoun C, Aymard M.
Influenza C virus infection in France. J
Infect. 1992;24:91–9.
3.  Claas EC, Sprenger MJ, Kleter GE, van
Beek R, Quint WG, Masurel N. Type-spe-
cific identification of influenza viruses A,
B, and C by the polymerase chain reaction.
J Virol Methods. 1992;39:1–13.
4. Greenbaum E, Morag A, Zakay-Rones Z.
Isolation of influenza C virus during out-
break of influenza A and B viruses. J Clin
Microbiol. 1998;36:1441–2.
5.  Hirsilä M, Kauppila J, Tuomaala K,
Grekula B, Puhakka T, Ruuskanen O, et al.
Detection by reverse transcription-poly-
merase chain reaction of influenza C in
nasopharyngeal secretions of adults with a
common cold. J Infect Dis.
2001;183:1269–72.
6. Moriuchi H, Katsushima N, Nishimura H,
Nakamura K, Numazaki Y. Community-
acquired influenza C virus infection in chil-
dren. J Pediatr. 1991;118:235–8.
7.  Coiras MT, Perez-Brena P, Garcia ML,
Casas I. Simultaneous detection of influen-
za A, B, and C viruses, respiratory syncytial
virus, and adenoviruses in clinical samples
by multiplex reverse transcription nested-
PCR assay. J Med Virol. 2003;69:132–44.
8. Neuzil KM, Zhu Y, Griffin MR, Edwards
KM, Thompson JM, Tollefson SJ, et al.
Burden of interpandemic influenza in chil-
dren younger than 5 years: a 25-year
prospective study. J Infect Dis. 2002;185:
147–52.
9. Ploin D, Liberas S, Thouvenot D, Fouilhoux
A, Gillet Y, Denis A, et al. Influenza burden
in children newborn to eleven months of age
in a pediatric emergency department during
the peak of an influenza epidemic. Pediatr
Infect Dis J. 2003;22:S218–22.
10. Katagiri S, Ohizumi A, Ohyama S, Homma
M. Follow-up study of type C influenza
outbreak in a children’s home. Microbiol
Immunol. 1987;31:337–43.
Address for correspondence: Cristina Calvo,
C/Viento 5, 5A, 28760 Tres Cantos, Madrid,
Spain; email: ccalvo@mi.madritel.es
Table. Characteristics of 6 children with influenza C virus infections, Spain 1999–2003* 
  Patient 
Characteristic  1  2  3  4  5  6 
Age, mo.  12  15  24  3.5  11  7 
Admission date  Jan 2000  Feb 2000  Mar 2000  Jan 2002  Nov 2002  Feb 2003 
Sex  F  M  M  F  M  F 
Temperature >38.5°C  Yes  Yes  Yes  Yes  Yes  Yes 
Fever duration, d  15  5  3  10  2  2 
Chest radiograph  Infiltrate  Normal  Infiltrate  Normal  Normal  Infiltrate 
Diagnosis  Wheeze  Wheeze  Pneumonia  Bronchiolitis  Wheeze  Wheeze 
O2 saturation <95%  No  Yes  No  No  Yes  Yes 
Days in hospital  9  8  2  2  2  13 
Coinfection  No  No  Adenovirus  RSV-B  RSV-B  No 
Diarrhea  Yes†  No  Yes‡  No  No  Yes† 
*RSV-B, respiratory syncytial virus B. 
†Rotavirus in feces. 
‡Adenovirus in feces. 